http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102886015-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4b86396970ea2b026ac2b8e5d250907 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate | 2011-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27e6c11397d0d8c133081c752f99abc |
| publicationDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102886015-B |
| titleOfInvention | Preparation for restoring consciousness and calming nasal mucosa and preparation method thereof |
| abstract | The invention discloses a preparation for restoring consciousness and calming nasal mucosa and a preparation method thereof. The preparation is a nasal drug composition preparation for treating cerebrovascular diseases. The nasal drug composition preparation is prepared from 30 to 50 parts by weight of borneol (or L-borneol), 3 to 9 parts by volume of synthetic musk essential oil, 2 to 6 parts by volume of turmeric root tuber essential oil and 30 to 40 parts by weight of cape jasmine fruit extract. The nasal drug composition preparation produces treatment effects through being absorbed by nasal mucosa and the nasal mucosa absorption process is mainly a passive absorption process. Drugs and fat-soluble drugs having relative molecular weight less than 1000 can be absorbed easily. The nasal drug composition preparation has high bioavailability near to 100%. |
| priorityDate | 2011-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.